Kevin F. McLaughlin is CFO & VP +1 at ACCELERON PHARMA INC (XLRN). They have made 23 open-market trades across 3 companies since 2014, most recently 2026-08-12.
CIK 0001214938
1 open-market purchase totalling $125K since 2025, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XLRN | 10,681 | $1.9M |
| VCEL | 18,300 | $734K |
| IVVD | 50,000 | $31K |
| DBTX | 5,000 | $25K |
| PRCS | 45,000 | — |
| Total | $2.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VCEL | SELL · 10b5-1 | 2026-08-12 | 2026-08-14 | $44.53 | $312K | -3.4% | -9.9% | — |
| VCEL | SELL · 10b5-1 | 2026-05-13 | 2026-05-15 | $32.83 | $230K | +3.1% | +15.3% | +34.0% |
| VCEL | SELL | 2026-02-11 | 2026-02-13 | $34.66 | $243K | +4.5% | -10.5% | -8.2% |
| IVVD | BUY | 2025-11-19 | 2025-11-20 | $2.50 | $125K | -9.0% | +17.6% | -32.7% |
| VCEL | SELL · 10b5-1 | 2025-11-10 | 2025-11-12 | $38.59 | $270K | -2.2% | -8.1% | -10.4% |
| VCEL | SELL · 10b5-1 | 2025-08-06 | 2025-08-08 | $35.92 | $251K | -2.6% | -8.5% | +6.7% |
| VCEL | SELL · 10b5-1 | 2025-05-07 | 2025-05-09 | $39.98 | $280K | -4.9% | +1.5% | -16.3% |
| VCEL | SELL · 10b5-1 | 2025-02-12 | 2025-02-14 | $55.46 | $388K | -13.2% | -16.7% | -27.4% |
| VCEL | SELL · 10b5-1 | 2024-11-13 | 2024-11-15 | $55.54 | $389K | +10.5% | +8.1% | +8.7% |
| VCEL | SELL · 10b5-1 | 2024-08-07 | 2024-08-09 | $45.94 | $322K | +6.0% | -3.2% | +10.3% |
| XLRN | SELL | 2021-09-23 | 2021-09-24 | $160.33 | $8.0M | +1.3% | +0.5% | N/A |
| XLRN | SELL | 2021-01-04 | 2021-01-06 | $123.37 | $821K | +7.6% | +4.0% | +12.6% |
| XLRN | SELL | 2020-12-14 | 2020-12-15 | $130.14 | $11.1M | -1.1% | -1.0% | +8.3% |
| XLRN | SELL | 2020-12-09 | 2020-12-11 | $125.03 | $1.4M | +0.5% | -9.7% | +3.0% |
| XLRN | SELL | 2020-04-08 | 2020-04-10 | $86.58 | $7.8M | +7.5% | +19.3% | +14.3% |
| XLRN | SELL | 2020-01-02 | 2020-01-03 | $52.51 | $465K | +8.0% | +85.0% | +66.2% |
| XLRN | SELL | 2019-12-13 | 2019-12-17 | $50.28 | $1.2M | +0.9% | +7.9% | +39.4% |
| XLRN | SELL | 2019-09-10 | 2019-09-10 | $45.30 | $362K | -5.7% | -16.1% | +9.2% |
| XLRN | SELL | 2019-09-10 | 2019-09-10 | $45.29 | $354K | -5.7% | -16.1% | +9.2% |
| XLRN | SELL | 2019-04-09 | 2019-04-11 | $44.62 | $535K | -7.1% | -6.9% | -5.0% |
| XLRN | SELL · 10b5-1 | 2019-04-02 | 2019-04-04 | $48.02 | $31K | -7.7% | -9.8% | -8.1% |
| XLRN | SELL | 2019-01-02 | 2019-01-04 | $42.80 | $244K | +2.4% | +3.4% | +10.7% |
| XLRN | SELL | 2019-01-02 | 2019-01-04 | $42.76 | $227K | +2.4% | +3.4% | +10.7% |
| XLRN | SELL | 2018-08-30 | 2018-08-31 | $54.00 | $675K | -4.6% | +3.9% | -1.3% |
| XLRN | SELL | 2018-06-29 | 2018-07-03 | $48.00 | $1.2M | -1.8% | -6.8% | +19.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.